Comparative efficacy and safety of Chinese patent medicines as an adjunctive therapy for diabetic peripheral neuropathy: systematic review and network meta-analysis of randomized controlled trials

Qun Wang,Hui Xie,Zihong Wang,Runyun Huang,Min Xu,Yongjun Li,Lingling Shan,Hongyan Zhang,Xianghong Liu,Hongxing Zhang,Yunsheng Xu,Shiguang Sun
DOI: https://doi.org/10.1080/13880209.2024.2422084
2024-11-06
Pharmaceutical Biology
Abstract:Context Diabetic peripheral neuropathy (DPN) is the most common complication of diabetes mellitus. Chinese patent medicines (CPMs) are widely used in clinical practice to treat DPN.
pharmacology & pharmacy,medical laboratory technology,plant sciences
What problem does this paper attempt to address?